If you are pregnant, breastfeeding, or taking medications, speak to a qualified provider to see if these treatments are appropriate
Molecular regulation of exercise-induced muscle fiber hypertrophy
It's in the reconstitution stage, temperature management during storage, and dose titration schedules that match your research objectives
CwynarAOlszewska-SoninaDCzajkowskiRZegarskaBBiaeckaAMciska-JundziKet al
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year